LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 8 of total 8

Search options

  1. Article ; Online: EBNA3C Directs Recruitment of RBPJ (CBF1) to Chromatin during the Process of Gene Repression in EBV Infected B Cells.

    Kalchschmidt, Jens S / Gillman, Adam C T / Paschos, Kostas / Bazot, Quentin / Kempkes, Bettina / Allday, Martin J

    PLoS pathogens

    2016  Volume 12, Issue 1, Page(s) e1005383

    Abstract: It is well established that Epstein-Barr virus nuclear antigen 3C (EBNA3C) can act as a potent repressor of gene expression, but little is known about the sequence of events occurring during the repression process. To explore further the role of EBNA3C ... ...

    Abstract It is well established that Epstein-Barr virus nuclear antigen 3C (EBNA3C) can act as a potent repressor of gene expression, but little is known about the sequence of events occurring during the repression process. To explore further the role of EBNA3C in gene repression-particularly in relation to histone modifications and cell factors involved-the three host genes previously reported as most robustly repressed by EBNA3C were investigated. COBLL1, a gene of unknown function, is regulated by EBNA3C alone and the two co-regulated disintegrin/metalloproteases, ADAM28 and ADAMDEC1 have been described previously as targets of both EBNA3A and EBNA3C. For the first time, EBNA3C was here shown to be the main regulator of all three genes early after infection of primary B cells. Using various EBV-recombinants, repression over orders of magnitude was seen only when EBNA3C was expressed. Unexpectedly, full repression was not achieved until 30 days after infection. This was accurately reproduced in established LCLs carrying EBV-recombinants conditional for EBNA3C function, demonstrating the utility of the conditional system to replicate events early after infection. Using this system, detailed chromatin immunoprecipitation analysis revealed that the initial repression was associated with loss of activation-associated histone modifications (H3K9ac, H3K27ac and H3K4me3) and was independent of recruitment of polycomb proteins and deposition of the repressive H3K27me3 modification, which were only observed later in repression. Most remarkable, and in contrast to current models of RBPJ in repression, was the observation that this DNA-binding factor accumulated at the EBNA3C-binding sites only when EBNA3C was functional. Transient reporter assays indicated that repression of these genes was dependent on the interaction between EBNA3C and RBPJ. This was confirmed with a novel EBV-recombinant encoding a mutant of EBNA3C unable to bind RBPJ, by showing this virus was incapable of repressing COBLL1 or ADAM28/ADAMDEC1 in newly infected primary B cells.
    MeSH term(s) B-Lymphocytes/virology ; Cells, Cultured ; Chromatin/genetics ; Chromatin Immunoprecipitation ; Epstein-Barr Virus Infections/genetics ; Epstein-Barr Virus Nuclear Antigens/genetics ; Gene Expression Regulation, Viral/genetics ; Host-Parasite Interactions/genetics ; Humans ; Immunoglobulin J Recombination Signal Sequence-Binding Protein/genetics ; Reverse Transcriptase Polymerase Chain Reaction
    Chemical Substances Chromatin ; EBNA-3C, epstein-barr virus ; Epstein-Barr Virus Nuclear Antigens ; Immunoglobulin J Recombination Signal Sequence-Binding Protein ; RBPJ protein, human
    Language English
    Publishing date 2016-01-11
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2205412-1
    ISSN 1553-7374 ; 1553-7366
    ISSN (online) 1553-7374
    ISSN 1553-7366
    DOI 10.1371/journal.ppat.1005383
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Epstein-Barr Virus Proteins EBNA3A and EBNA3C Together Induce Expression of the Oncogenic MicroRNA Cluster miR-221/miR-222 and Ablate Expression of Its Target p57KIP2.

    Bazot, Quentin / Paschos, Kostas / Skalska, Lenka / Kalchschmidt, Jens S / Parker, Gillian A / Allday, Martin J

    PLoS pathogens

    2015  Volume 11, Issue 7, Page(s) e1005031

    Abstract: We show that two host-encoded primary RNAs (pri-miRs) and the corresponding microRNA (miR) clusters--widely reported to have cell transformation-associated activity--are regulated by EBNA3A and EBNA3C. Utilising a variety of EBV-transformed ... ...

    Abstract We show that two host-encoded primary RNAs (pri-miRs) and the corresponding microRNA (miR) clusters--widely reported to have cell transformation-associated activity--are regulated by EBNA3A and EBNA3C. Utilising a variety of EBV-transformed lymphoblastoid cell lines (LCLs) carrying knockout-, revertant- or conditional-EBV recombinants, it was possible to demonstrate unambiguously that EBNA3A and EBNA3C are both required for transactivation of the oncogenic miR-221/miR-222 cluster that is expressed at high levels in multiple human tumours--including lymphoma/leukemia. ChIP, ChIP-seq, and chromosome conformation capture analyses indicate that this activation results from direct targeting of both EBV proteins to chromatin at the miR-221/miR-222 genomic locus and activation via a long-range interaction between enhancer elements and the transcription start site of a long non-coding pri-miR located 28 kb upstream of the miR sequences. Reduced levels of miR-221/miR-222 produced by inactivation or deletion of EBNA3A or EBNA3C resulted in increased expression of the cyclin-dependent kinase inhibitor p57KIP2, a well-established target of miR-221/miR-222. MiR blocking experiments confirmed that miR-221/miR-222 target p57KIP2 expression in LCLs. In contrast, EBNA3A and EBNA3C are necessary to silence the tumour suppressor cluster miR-143/miR-145, but here ChIP-seq suggests that repression is probably indirect. This miR cluster is frequently down-regulated or deleted in human cancer, however, the targets in B cells are unknown. Together these data indicate that EBNA3A and EBNA3C contribute to B cell transformation by inhibiting multiple tumour suppressor proteins, not only by direct repression of protein-encoding genes, but also by the manipulation of host long non-coding pri-miRs and miRs.
    MeSH term(s) B-Lymphocytes/virology ; Blotting, Western ; Cell Transformation, Neoplastic/genetics ; Chromatin Immunoprecipitation ; Cyclin-Dependent Kinase Inhibitor p57/biosynthesis ; Epstein-Barr Virus Nuclear Antigens/genetics ; Epstein-Barr Virus Nuclear Antigens/metabolism ; Flow Cytometry ; Gene Expression Regulation, Neoplastic/genetics ; Humans ; Immunoprecipitation ; MicroRNAs/biosynthesis ; MicroRNAs/genetics ; Oncogenes ; Real-Time Polymerase Chain Reaction
    Chemical Substances Cyclin-Dependent Kinase Inhibitor p57 ; EBNA-3A antigen ; EBNA-3C, epstein-barr virus ; Epstein-Barr Virus Nuclear Antigens ; MIRN221 microRNA, human ; MIRN222 microRNA, human ; MicroRNAs
    Language English
    Publishing date 2015-07-08
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2205412-1
    ISSN 1553-7374 ; 1553-7366
    ISSN (online) 1553-7374
    ISSN 1553-7366
    DOI 10.1371/journal.ppat.1005031
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Epstein-Barr virus nuclear protein EBNA3C directly induces expression of AID and somatic mutations in B cells.

    Kalchschmidt, Jens S / Bashford-Rogers, Rachael / Paschos, Kostas / Gillman, Adam C T / Styles, Christine T / Kellam, Paul / Allday, Martin J

    The Journal of experimental medicine

    2016  Volume 213, Issue 6, Page(s) 921–928

    Abstract: Activation-induced cytidine deaminase (AID), the enzyme responsible for induction of sequence variation in immunoglobulins (Igs) during the process of somatic hypermutation (SHM) and also Ig class switching, can have a potent mutator phenotype in the ... ...

    Abstract Activation-induced cytidine deaminase (AID), the enzyme responsible for induction of sequence variation in immunoglobulins (Igs) during the process of somatic hypermutation (SHM) and also Ig class switching, can have a potent mutator phenotype in the development of lymphoma. Using various Epstein-Barr virus (EBV) recombinants, we provide definitive evidence that the viral nuclear protein EBNA3C is essential in EBV-infected primary B cells for the induction of AID mRNA and protein. Using lymphoblastoid cell lines (LCLs) established with EBV recombinants conditional for EBNA3C function, this was confirmed, and it was shown that transactivation of the AID gene (AICDA) is associated with EBNA3C binding to highly conserved regulatory elements located proximal to and upstream of the AICDA transcription start site. EBNA3C binding initiated epigenetic changes to chromatin at specific sites across the AICDA locus. Deep sequencing of cDNA corresponding to the IgH V-D-J region from the conditional LCL was used to formally show that SHM is activated by functional EBNA3C and induction of AID. These data, showing the direct targeting and induction of functional AID by EBNA3C, suggest a novel role for EBV in the etiology of B cell cancers, including endemic Burkitt lymphoma.
    MeSH term(s) Burkitt Lymphoma/genetics ; Burkitt Lymphoma/immunology ; Cell Line ; Cytidine Deaminase/genetics ; Cytidine Deaminase/immunology ; Epstein-Barr Virus Nuclear Antigens/genetics ; Epstein-Barr Virus Nuclear Antigens/immunology ; Female ; Gene Expression Regulation, Enzymologic/immunology ; Gene Expression Regulation, Neoplastic/genetics ; Gene Expression Regulation, Neoplastic/immunology ; Gene Rearrangement, B-Lymphocyte/genetics ; Gene Rearrangement, B-Lymphocyte/immunology ; Herpesvirus 4, Human/genetics ; Herpesvirus 4, Human/immunology ; Humans ; Male ; Neoplasm Proteins/genetics ; Neoplasm Proteins/immunology ; Response Elements/immunology ; Somatic Hypermutation, Immunoglobulin/genetics ; Somatic Hypermutation, Immunoglobulin/immunology
    Chemical Substances EBNA-3C, epstein-barr virus ; Epstein-Barr Virus Nuclear Antigens ; Neoplasm Proteins ; AICDA (activation-induced cytidine deaminase) (EC 3.5.4.-) ; Cytidine Deaminase (EC 3.5.4.5)
    Language English
    Publishing date 2016-05-23
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 218343-2
    ISSN 1540-9538 ; 0022-1007
    ISSN (online) 1540-9538
    ISSN 0022-1007
    DOI 10.1084/jem.20160120
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: EBNA3C Directs Recruitment of RBPJ (CBF1) to Chromatin during the Process of Gene Repression in EBV Infected B Cells.

    Jens S Kalchschmidt / Adam C T Gillman / Kostas Paschos / Quentin Bazot / Bettina Kempkes / Martin J Allday

    PLoS Pathogens, Vol 12, Iss 1, p e

    2016  Volume 1005383

    Abstract: It is well established that Epstein-Barr virus nuclear antigen 3C (EBNA3C) can act as a potent repressor of gene expression, but little is known about the sequence of events occurring during the repression process. To explore further the role of EBNA3C ... ...

    Abstract It is well established that Epstein-Barr virus nuclear antigen 3C (EBNA3C) can act as a potent repressor of gene expression, but little is known about the sequence of events occurring during the repression process. To explore further the role of EBNA3C in gene repression-particularly in relation to histone modifications and cell factors involved-the three host genes previously reported as most robustly repressed by EBNA3C were investigated. COBLL1, a gene of unknown function, is regulated by EBNA3C alone and the two co-regulated disintegrin/metalloproteases, ADAM28 and ADAMDEC1 have been described previously as targets of both EBNA3A and EBNA3C. For the first time, EBNA3C was here shown to be the main regulator of all three genes early after infection of primary B cells. Using various EBV-recombinants, repression over orders of magnitude was seen only when EBNA3C was expressed. Unexpectedly, full repression was not achieved until 30 days after infection. This was accurately reproduced in established LCLs carrying EBV-recombinants conditional for EBNA3C function, demonstrating the utility of the conditional system to replicate events early after infection. Using this system, detailed chromatin immunoprecipitation analysis revealed that the initial repression was associated with loss of activation-associated histone modifications (H3K9ac, H3K27ac and H3K4me3) and was independent of recruitment of polycomb proteins and deposition of the repressive H3K27me3 modification, which were only observed later in repression. Most remarkable, and in contrast to current models of RBPJ in repression, was the observation that this DNA-binding factor accumulated at the EBNA3C-binding sites only when EBNA3C was functional. Transient reporter assays indicated that repression of these genes was dependent on the interaction between EBNA3C and RBPJ. This was confirmed with a novel EBV-recombinant encoding a mutant of EBNA3C unable to bind RBPJ, by showing this virus was incapable of repressing COBLL1 or ADAM28/ADAMDEC1 in newly ...
    Keywords Immunologic diseases. Allergy ; RC581-607 ; Biology (General) ; QH301-705.5
    Subject code 570
    Language English
    Publishing date 2016-01-01T00:00:00Z
    Publisher Public Library of Science (PLoS)
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article ; Online: A Pliable Mediator Acts as a Functional Rather Than an Architectural Bridge between Promoters and Enhancers.

    El Khattabi, Laila / Zhao, Haiyan / Kalchschmidt, Jens / Young, Natalie / Jung, Seolkyoung / Van Blerkom, Peter / Kieffer-Kwon, Philippe / Kieffer-Kwon, Kyong-Rim / Park, Solji / Wang, Xiang / Krebs, Jordan / Tripathi, Subhash / Sakabe, Noboru / Sobreira, Débora R / Huang, Su-Chen / Rao, Suhas S P / Pruett, Nathanael / Chauss, Daniel / Sadler, Erica /
    Lopez, Andrea / Nóbrega, Marcelo A / Aiden, Erez Lieberman / Asturias, Francisco J / Casellas, Rafael

    Cell

    2019  Volume 178, Issue 5, Page(s) 1145–1158.e20

    Abstract: ... We propose that Mediator's structural pliability enables it to integrate and transmit regulatory signals and ...

    Abstract While Mediator plays a key role in eukaryotic transcription, little is known about its mechanism of action. This study combines CRISPR-Cas9 genetic screens, degron assays, Hi-C, and cryoelectron microscopy (cryo-EM) to dissect the function and structure of mammalian Mediator (mMED). Deletion analyses in B, T, and embryonic stem cells (ESC) identified a core of essential subunits required for Pol II recruitment genome-wide. Conversely, loss of non-essential subunits mostly affects promoters linked to multiple enhancers. Contrary to current models, however, mMED and Pol II are dispensable to physically tether regulatory DNA, a topological activity requiring architectural proteins. Cryo-EM analysis revealed a conserved core, with non-essential subunits increasing structural complexity of the tail module, a primary transcription factor target. Changes in tail structure markedly increase Pol II and kinase module interactions. We propose that Mediator's structural pliability enables it to integrate and transmit regulatory signals and act as a functional, rather than an architectural bridge, between promoters and enhancers.
    MeSH term(s) Animals ; CD4-Positive T-Lymphocytes/cytology ; CD4-Positive T-Lymphocytes/metabolism ; CRISPR-Cas Systems/genetics ; Cell Cycle Proteins/metabolism ; Cells, Cultured ; Chromosomal Proteins, Non-Histone/metabolism ; Cryoelectron Microscopy ; Enhancer Elements, Genetic ; Gene Editing ; Humans ; Male ; Mediator Complex/chemistry ; Mediator Complex/genetics ; Mediator Complex/metabolism ; Mice ; Mice, Inbred C57BL ; Mouse Embryonic Stem Cells/cytology ; Mouse Embryonic Stem Cells/metabolism ; Promoter Regions, Genetic ; Protein Structure, Quaternary ; RNA Polymerase II/genetics ; RNA Polymerase II/metabolism ; Saccharomyces cerevisiae/metabolism ; Saccharomyces cerevisiae Proteins/metabolism ; Cohesins
    Chemical Substances Cell Cycle Proteins ; Chromosomal Proteins, Non-Histone ; Mediator Complex ; Saccharomyces cerevisiae Proteins ; RNA Polymerase II (EC 2.7.7.-)
    Language English
    Publishing date 2019-08-08
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 187009-9
    ISSN 1097-4172 ; 0092-8674
    ISSN (online) 1097-4172
    ISSN 0092-8674
    DOI 10.1016/j.cell.2019.07.011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Epstein-Barr Virus Proteins EBNA3A and EBNA3C Together Induce Expression of the Oncogenic MicroRNA Cluster miR-221/miR-222 and Ablate Expression of Its Target p57KIP2.

    Quentin Bazot / Kostas Paschos / Lenka Skalska / Jens S Kalchschmidt / Gillian A Parker / Martin J Allday

    PLoS Pathogens, Vol 11, Iss 7, p e

    2015  Volume 1005031

    Abstract: We show that two host-encoded primary RNAs (pri-miRs) and the corresponding microRNA (miR) clusters--widely reported to have cell transformation-associated activity--are regulated by EBNA3A and EBNA3C. Utilising a variety of EBV-transformed ... ...

    Abstract We show that two host-encoded primary RNAs (pri-miRs) and the corresponding microRNA (miR) clusters--widely reported to have cell transformation-associated activity--are regulated by EBNA3A and EBNA3C. Utilising a variety of EBV-transformed lymphoblastoid cell lines (LCLs) carrying knockout-, revertant- or conditional-EBV recombinants, it was possible to demonstrate unambiguously that EBNA3A and EBNA3C are both required for transactivation of the oncogenic miR-221/miR-222 cluster that is expressed at high levels in multiple human tumours--including lymphoma/leukemia. ChIP, ChIP-seq, and chromosome conformation capture analyses indicate that this activation results from direct targeting of both EBV proteins to chromatin at the miR-221/miR-222 genomic locus and activation via a long-range interaction between enhancer elements and the transcription start site of a long non-coding pri-miR located 28 kb upstream of the miR sequences. Reduced levels of miR-221/miR-222 produced by inactivation or deletion of EBNA3A or EBNA3C resulted in increased expression of the cyclin-dependent kinase inhibitor p57KIP2, a well-established target of miR-221/miR-222. MiR blocking experiments confirmed that miR-221/miR-222 target p57KIP2 expression in LCLs. In contrast, EBNA3A and EBNA3C are necessary to silence the tumour suppressor cluster miR-143/miR-145, but here ChIP-seq suggests that repression is probably indirect. This miR cluster is frequently down-regulated or deleted in human cancer, however, the targets in B cells are unknown. Together these data indicate that EBNA3A and EBNA3C contribute to B cell transformation by inhibiting multiple tumour suppressor proteins, not only by direct repression of protein-encoding genes, but also by the manipulation of host long non-coding pri-miRs and miRs.
    Keywords Immunologic diseases. Allergy ; RC581-607 ; Biology (General) ; QH301-705.5
    Subject code 500
    Language English
    Publishing date 2015-07-01T00:00:00Z
    Publisher Public Library of Science (PLoS)
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: In vivo time-lapse imaging shows diverse niche engagement by quiescent and naturally activated hematopoietic stem cells.

    Rashidi, Narges M / Scott, Mark K / Scherf, Nico / Krinner, Axel / Kalchschmidt, Jens S / Gounaris, Kleoniki / Selkirk, Murray E / Roeder, Ingo / Lo Celso, Cristina

    Blood

    2014  Volume 124, Issue 1, Page(s) 79–83

    Abstract: Hematopoietic stem cells (HSCs) maintain the turnover of mature blood cells during steady state and in response to systemic perturbations such as infections. Their function critically depends on complex signal exchanges with the bone marrow (BM) ... ...

    Abstract Hematopoietic stem cells (HSCs) maintain the turnover of mature blood cells during steady state and in response to systemic perturbations such as infections. Their function critically depends on complex signal exchanges with the bone marrow (BM) microenvironment in which they reside, but the cellular mechanisms involved in HSC-niche interactions and regulating HSC function in vivo remain elusive. We used a natural mouse parasite, Trichinella spiralis, and multipoint intravital time-lapse confocal microscopy of mouse calvarium BM to test whether HSC-niche interactions may change when hematopoiesis is perturbed. We find that steady-state HSCs stably engage confined niches in the BM whereas HSCs harvested during acute infection are motile and therefore interact with larger niches. These changes are accompanied by increased long-term repopulation ability and expression of CD44 and CXCR4. Administration of a CXCR4 antagonist affects the duration of HSC-niche interactions. These findings suggest that HSC-niche interactions may be modulated during infection.
    MeSH term(s) Animals ; Bone Marrow/immunology ; Bone Marrow/metabolism ; Hematopoiesis/physiology ; Hematopoietic Stem Cells/cytology ; Hematopoietic Stem Cells/immunology ; Hematopoietic Stem Cells/metabolism ; Hyaluronan Receptors/immunology ; Hyaluronan Receptors/metabolism ; Mice ; Microscopy, Confocal ; Receptors, CXCR4/immunology ; Receptors, CXCR4/metabolism ; Stem Cell Niche/physiology ; Time-Lapse Imaging ; Trichinella spiralis ; Trichinellosis/immunology ; Trichinellosis/metabolism
    Chemical Substances CXCR4 protein, mouse ; Cd44 protein, mouse ; Hyaluronan Receptors ; Receptors, CXCR4
    Language English
    Publishing date 2014-05-21
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80069-7
    ISSN 1528-0020 ; 0006-4971
    ISSN (online) 1528-0020
    ISSN 0006-4971
    DOI 10.1182/blood-2013-10-534859
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: A Pliable Mediator Acts as a Functional Rather Than an Architectural Bridge between Promoters and Enhancers

    El Khattabi, Laila / Aiden, Erez Lieberman / Asturias, Francisco J / Casellas, Rafael / Chauss, Daniel / Huang, Su-Chen / Jung, Seolkyoung / Kalchschmidt, Jens / Kieffer-Kwon, Kyong-Rim / Kieffer-Kwon, Philippe / Krebs, Jordan / Lopez, Andrea / Nóbrega, Marcelo A / Park, Solji / Pruett, Nathanael / Rao, Suhas S.P / Sadler, Erica / Sakabe, Noboru / Sobreira, Débora R /
    Tripathi, Subhash / Van Blerkom, Peter / Wang, Xiang / Young, Natalie / Zhao, Haiyan

    Cell. 2019 Aug. 22, v. 178, no. 5

    2019  

    Abstract: ... We propose that Mediator’s structural pliability enables it to integrate and transmit regulatory signals and ...

    Abstract While Mediator plays a key role in eukaryotic transcription, little is known about its mechanism of action. This study combines CRISPR-Cas9 genetic screens, degron assays, Hi-C, and cryoelectron microscopy (cryo-EM) to dissect the function and structure of mammalian Mediator (mMED). Deletion analyses in B, T, and embryonic stem cells (ESC) identified a core of essential subunits required for Pol II recruitment genome-wide. Conversely, loss of non-essential subunits mostly affects promoters linked to multiple enhancers. Contrary to current models, however, mMED and Pol II are dispensable to physically tether regulatory DNA, a topological activity requiring architectural proteins. Cryo-EM analysis revealed a conserved core, with non-essential subunits increasing structural complexity of the tail module, a primary transcription factor target. Changes in tail structure markedly increase Pol II and kinase module interactions. We propose that Mediator’s structural pliability enables it to integrate and transmit regulatory signals and act as a functional, rather than an architectural bridge, between promoters and enhancers.
    Keywords CRISPR-Cas systems ; cryo-electron microscopy ; DNA ; embryonic stem cells ; enzymes ; mammals ; mechanism of action ; models ; topology ; transcription factors
    Language English
    Dates of publication 2019-0822
    Size p. 1145-1158.e20.
    Publishing place Elsevier Inc.
    Document type Article
    ZDB-ID 187009-9
    ISSN 1097-4172 ; 0092-8674
    ISSN (online) 1097-4172
    ISSN 0092-8674
    DOI 10.1016/j.cell.2019.07.011
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

To top